Association of lipid peroxidation with endothelial dysfunction in patients with overt hypothyroidism

Experimental and Clinical Endocrinology and Diabetes

Volumn 121, Issue 5, 2013, Pages 306-309

  Tejovathi, B ^a   Suchitra, M M ^a   Suresh, V ^a   Reddy, V S ^a   Sachan, A ^a   Srinivas Rao, P V L N ^a   Bitla, A R ^a  

^a SRI VENKATESWARA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

asymmetric dimethyl arginine; hypothyroidism; malondialdehyde; nitrates; oxidative stress

Indexed keywords

LIPID; MALONALDEHYDE; N(G),N(G) DIMETHYLARGININE; NITRATE; REACTIVE OXYGEN METABOLITE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HYPOTHYROIDISM; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADULT; ANTIOXIDANTS; ARGININE; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPOTHYROIDISM; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NITRIC OXIDE; RISK FACTORS;

EID: 84877840366     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0032-1333298     Document Type: Article

References (33)

1. Vallance P., Collier J., Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet: 1989; 2 997 1000 (Pubitemid 19257913)
2. Vallance P., Leone A., Calver A. et al. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet: 1992; 339 572 575
3. Kojda G., Harrison D. Interactions between NO and reactive oxygen species: Pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res: 1999; 43 562 571 (Pubitemid 29369255)
4. Cai H., Harrison D. G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res: 2000; 87 840 844
5. Napoli R., Biondi B., Guardasole V. et al. Impact of hyperthyroidism and its correction on vascular reactivity in humans. Circulation: 2001; 104 3076 3080 (Pubitemid 34014060)
6. Arikan E., Karadag C. H., Guldiken S. Asymmetric dimethylarginine levels in thyroid diseases. J Endocrinol Invest: 2007; 30 186 191 (Pubitemid 46929316)
7. Ozcan O., Cakir E., Yaman H. et al. The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism. Clin Endocrinol: 2005; 63 203 206 (Pubitemid 41097990)
8. Ojamaa K., Klemperer J. D., Klein I. Acute effects of thyroid hormone on vascular smooth muscle. Thyroid: 1996; 6 505 512 (Pubitemid 26398659)
9. Tan F. P., Reuters V. S., Ferreira M. M. et al. Lipid profile in different degrees of hypothyroidism and effects of levothyroxine replacement in mild thyroid failure. J Lab Clin Med: 2008; 151 224 231 (Pubitemid 351384829)
10. Saito I., Saruta T. Hypertension in thyroid disorders. Endocrinol Metab Clin North Am: 1994; 23 379 386 (Pubitemid 24191811)
11. Nagasaki T., Inaba M., Shirakawa K. et al. Increased levels of C-reactive protein in hypothyroid Patients and Its correlation with arterial stiffness in the common carotid artery. Biomed Pharmacother: 2007; 61 167 172 (Pubitemid 46561189)
12. Nedrebo B. G., Ericsson U. B., Nygård O. et al. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism: 1998; 47 89 93 (Pubitemid 28086238)
13. Santi A., Duarte M. M., Moresco R. N. et al. Association between thyroid hormones, lipids and oxidative stress biomarkers in overt hypothyroidism. Clin Chem Lab Med: 2010; 48 1635 1639
14. Klein I., Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med: 2001; 344 501 509 (Pubitemid 32164903)
15. Lekakis J., Papamichael C., Alevizaki M. et al. Flow-mediated, endothelium-dependent vasodilation is impaired in Subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid: 1997; 7 411 414 (Pubitemid 27295140)
16. Erbil Y., Ozbey N., Giriş M. et al. Effects of thyroxine replacement on lipid profile and endothelial function after thyroidectomy. Br J Surg: 2007; 94 1485 1490 (Pubitemid 350275626)
17. Papaioannou G. Treating hypothyroidism Improves endothelial function. Metabolism: 2004; 53 278 279 (Pubitemid 38684684)
18. Shavdatuashvili T. Lipoprotein profile and endothelial function in patients with subclinical and overt hypothyroidism. Georgian Med News: 2005; 129 57 60
19. Dagre A. G., Lekakis J. P., Protogerou A. D. et al. Abnormal endothelial function in female patients with hypothyroidism and borderline thyroid function. Int J Cardiol: 2007; 114 332 338 Epub 2006 Jun 21 (Pubitemid 44855911)
20. Kocak H., Ceken K., Yavuz A. et al. Effect of renal transplantation on endothelial function in haemodialysis patients. Nephrol Dial Transplant: 2006; 21 203 207 (Pubitemid 43057131)
21. Casey D. P., Beck D. T., Braith R. W. Systemic plasma levels of nitrite/nitrate (Nox) reflect brachial flow-mediated dilation responses in young men and women. Clin Exp Pharmacol Physiol: 2007; 34 1291 1293 (Pubitemid 350013239)
22. Engin A. B., Sepici-Dincel A., Gonul I. I. et al. Oxidative stress-induced endothelial cell damage in thyroidectomized rat. Exp Toxicol Pathol: 2012; 64 481 485 Epub 2010 Dec 4
23. Sangeetha P., Das U. N., Koratkar R. et al. Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer. Free radical Bio Med: 1990; 8 15 19
24. Cortas N. K., Wakid N. W. Determination of inorganic nitrate in serum and urine by kinetic cadmium reduction method. Clin chem: 1990; 36 1440 1443
25. Rajendra W. High performance liquid chromatography determination of amino acids in biological samples by pre column derivatization with O-pthaldialdehyde. J liq chromatogr: 1987; 10 941 955 (Pubitemid 17107395)
26. Torun A. N., Kulaksizoglu S., Kulaksizoglu M. et al. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism. Clin Endocrinol: 2009; 70 469 474
27. Zoccali C. Asymmetric dimethylarginine in end-stage renal disease patients: A biomarker modifiable by calcium blockade and angiotensin II antagonism? Kidney Int: 2006; 70 2053 2055 (Pubitemid 44871366)
28. Jun-Hyun Y., Sung-Chang L. Elevated levels of plasma homocyst[e]ine and asymmetric dimethylarginine in elderly patients with stroke. Atherosclerosis: 2001; 158 425 430
29. Cardounel A. J., Cui H., Samouilov A. et al. Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function. J Biol Chem: 2007; 282 879 887 (Pubitemid 47076535)
30. Higashi Y., Noma K., Yoshizumi M. et al. Endothelial Function and Oxidative Stress in Cardiovascular Diseases. Circ J: 2009; 73 411 418
31. Stehouwer CD A., Lambert J., Donker AJ M. et al. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovas Res: 1997; 34 55 68 (Pubitemid 27261913)
32. Clausen P., Mersebach H., Nielsen B. et al. Hypothyroidism is associated with signs of endothelial dysfunction despite 1-year replacement therapy with levothyroxine. Clin Endocrinol (Oxf): 2009; 70 932 937 Epub 2008 Sep 5
33. Lane H. A., Smith J. C., Davies J. S. Noninvasive assessment of preclinical atherosclerosis. Vasc Health Risk Manag: 2006; 2 19 30